Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

January 17, 2021

Home Care Aide Safety Concerns and Job Challenges During the COVID-19 Pandemic

New Solutions : a Journal of Environmental and Occupational Health Policy : NS
Julia BandiniJason Etchegaray
January 17, 2021
Open Access

Low influenza vaccination coverage among hospitalized COVID-19 patients in Milan: A gap to be urgently filled

European Journal of Internal Medicine
Anna Lisa RidolfoSpinello Antinori
January 17, 2021

Modelling the effect of the COVID-19 pandemic on violent discipline against children

Child Abuse & Neglect
Camilla FabbriKaren Devries
January 17, 2021

An EUA for baricitinib (Olumiant) for COVID-19

The Medical Letter on Drugs and Therapeutics
January 17, 2021
Open Access

COVID-19 narratives from the New York Roentgen Society

Clinical Imaging
O Kenechi Nwawka, Janine T Katzen
January 17, 2021
Open Access

Dysregulation of Cell Signaling by SARS-CoV-2

Trends in Microbiology
Rahul K SuryawanshiDeepak Shukla
January 17, 2021

Novel Regeneration Approach for Creating Reusable FO-SPR Probes with NTA Surface Chemistry

Jia-Huan QuJeroen Lammertyn
January 17, 2021
Open Access

Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs

Florence RodgersVictoria Pilkington
January 18, 2021
Open Access

Acute Endotheliitis (Type 3 Hypersensitivity Vasculitis) in Ten COVID-19 Autopsy Brains

MedRxiv : the Preprint Server for Health Sciences
Roy H RhodesR. S. Vander Heide
January 17, 2021
Open Access

Slump in Hospital Admissions for Stroke, a Fact of an Uncertain Nature That Requires Explanation

Brain Sciences
José M Ramírez-MorenoLuis Fernández de Alarcón
January 17, 2021

An EUA for casirivimab and imdevimab for COVID-19

The Medical Letter on Drugs and Therapeutics
January 17, 2021

COVID-19 preventive behaviors and influencing factors in the Iranian population; a web-based survey

BMC Public Health
Mojgan FirouzbakhtArman Asadi-Amoli
January 17, 2021
Open Access

Pregnant women's well-being and worry during the COVID-19 pandemic: a cross-sectional study

BMC Pregnancy and Childbirth
Forough MortazaviRoya KiaeeTabar
January 17, 2021
Open Access

Corrigendum to isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak [Int. J. Infect. Dis. 99 (2020) 40-46

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Liubov KozlovskayaAydar Ishmukhametov
January 17, 2021

Anesthesia for extraction of a fractured COVID-19 nasopharyngeal swab

International Journal of Pediatric Otorhinolaryngology
Varun Suresh
January 17, 2021
Open Access

SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study

Transplantation Proceedings
Conrad RauberChristian Rupp
January 17, 2021
Open Access

COVID-19 in IBD: The experience of a single tertiary IBD center

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Fernando RizzelloPaolo Gionchetti
December 24, 2020
Open Access

Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York

Molecular Genetics and Metabolism
Luca FierroManisha Balwani

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

© 2021 Meta ULC. All rights reserved